Genervon Shares Alzheimer’s Gene List Linked to Its GM6 Treatment

Genervon Shares Alzheimer’s Gene List Linked to Its GM6 Treatment
Genervon Biopharmaceuticals recently shared a previously confidential list of 84 genes linked to Alzheimer’s disease which are modulated by their investigational treatment GM6. The move to make the list public was based on a wish to encourage more neurological scientists to investigate broader, multi-target approaches to treat diseases such as Alzheimer’s and ALS (amyotrophic lateral

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *